CS Paper Radar

CRISS: A Retrieval-Augmented AI Chatbot for Assisting Cancer Registrars

Vani Seth, Mohammad Beheshti, Anirudh Kambhampati, Vishwa Bhayani, Lucinda Ham, Prasad Calyam, Iris Zachary

cs.AI cs.CL ·submitted 2026-09-24 06:05 UTC · v1

Abstract

Cancer registrars, including Oncology Data Specialists (ODSs), must interpret complex and frequently updated coding and staging standards. We developed CRISS (Cancer Registry Intelligent Support System), a retrieval-augmented generation (RAG) conversational assistant that provides rapid, citation-supported access to registry guidance. This study evaluated whether CRISS could (1) support accurate and citation-supported responses, (2) improve access to and interpretation of relevant guidance, and (3) support training/helpdesk use while preserving human oversight of final abstraction decisions. We built a domain-specific knowledge base from national cancer registry standards, segmented into metadata-tagged passages and indexed as dense embeddings. Retrieved passages were used to generate citation-grounded responses through a large language model (LLM). Open-weight, proprietary, and non-RAG baseline models across Gemini and GPT families were evaluated on easy, medium, and hard registry questions using an LLM-as-a-Judge protocols. RAG configurations consistently outperformed non-RAG approaches, especially as question difficulty increased. Mean grounding scores for RAG were 0.62/0.56/0.59 across easy/medium/hard tiers versus 0.29/0.26/0.29 for non-RAG. RAG models also achieved higher semantic-similarity scores overall. Proprietary RAG models performed strongest on easy and medium questions, while local RAG models ranked highest on hard questions and proprietary models were generally more cautious. Domain-specific RAG improved evidence grounding and response quality for cancer registry questions while enabling citation-supported assistance across complexity levels. CRISS demonstrates the potential of human-centered, citation-grounded AI to support cancer registrars while preserving human oversight for final coding decisions.

Comment
21 pages, 13 figures, 7 tables. Keywords: cancer registry, retrieval-augmented generation, large language models, conversational AI, clinical informatics, oncology data specialists, medical question answering, AI safety, clinical decision support

Closest papers

Nearest neighbours by meaning across the whole index.

"I Know Where to Look," But Does the LLM? Charting the Gaps Between Clinical Expert Needs and Unstructured Data Abstraction Tools

cs.HC q-bio.OT ·2026-09-16 ·Venkatesh Sivaraman, Rigney Turnham, George Bonano, Nevin Aresh, Renumathy Dhanasekaran +14 more
similarity 0.72
Abstract · Under review

Clinical data abstraction, the process of distilling structured information from patient records, plays a key role in advancing knowledge about diseases such as cancer. Information extraction (IE) with large language models (LLMs) could accelerate this process, but it is unclear whether current frameworks effectively support clinical researchers without AI expertise. To address this, we co-designed an interactive LLM-based abstraction system called Libretto with seven cancer research teams, then evaluated the system's ability to help them answer real-world research questions. We found that while clinicians knew where and how to annotate complex concepts in patient notes, in twelve of fourteen tasks they faced barriers to replicating those intuitions with LLMs. Contextual note reliability judgments, difficulties in steering vibe-coded prompts, and inflexible evaluation strategies necessitated fundamental changes to the IE workflow. Our results highlight open problems for HCI research to bridge the gaps between AI data work tools and clinical users' needs.

0.07

ClinAgent: A ReAct-Based Agent for Conversational Access to Clinical Trial Information

cs.AI cs.CLcs.IR ·2026-09-12 ·Antonino Vaccarella, Riccardo Cantini, Domenico Talia, Paolo Trunfio, Marianna Talia +2 more
published similarity 0.71
Abstract · Accepted at the CIBB 2026 conference (https://cibb2026.teralab.ai/)

Querying clinical trial registries remains a manual and error-prone process, requiring researchers to navigate large volumes of semi-structured data without support for natural language interaction or cross-source synthesis. To address this, we introduce ClinAgent, a conversational system based on agentic Retrieval-Augmented Generation (RAG) that enables clinicians and researchers to query clinical trial information in plain language and receive grounded, up-to-date responses across multi-turn interactions. The system centers on a Large Language Model (LLM) agent following the ReAct paradigm, which iteratively reasons over queries, selects among a set of integrated tools, and refines its actions based on intermediate outputs. These tools include a ClinicalTrials.gov search interface, a PubMed module, and a Python-based analyzer operating on a locally cached structured dataset of clinical trials. We evaluate the system using a three-phase framework assessing operational effectiveness, planning quality, tool-use efficiency, and expert qualitative judgments, comparing three LLM backends: Gemini 3.0 Flash and two variants of DeepSeek V3.2 (thinking and non-thinking). Results reveal complementary strengths, with DeepSeek (thinking mode) excelling in planning quality, while Gemini achieves the highest overall performance and strongest expert ratings. Overall, our findings highlight the potential of agentic AI systems to improve the accessibility and synthesis of clinical trial information, supporting more efficient and user-centered biomedical research workflows.

0.29

Do AI chatbots find what experts would? Effects of model, user role, and sample size on study retrieval for medical questions

cs.IR cs.AIcs.CL ·2026-08-13 ·Qingfang Liu, Qiao Jin, Joe D. Menke, Thorsten Kahnt, Zhiyong Lu
similarity 0.69
Abstract

Large language model (LLM) chatbots are increasingly used to answer clinical questions with citations to relevant studies, yet the quality of retrieved evidence and factors influencing study selection remain unclear. We evaluated three general-purpose LLM chatbots (Claude Sonnet 5, Gemini 3.1 Pro, and ChatGPT GPT-5.5) using 20 clinical questions adapted from 2026 Cochrane reviews. We simulated patient, clinician, and evidence-synthesis researcher roles and obtained four independent responses for each chatbot-role-question combination, yielding 720 responses (3 chatbots $\times$ 3 user roles $\times$ 4 repetitions $\times$ 20 review questions). Chatbots were asked to support their answers with primary clinical citations, which were benchmarked against the included and excluded study sets of the corresponding Cochrane reviews. On average, a single response retrieved 39.2% $\pm$ 29.8% of the corresponding Cochrane included-study set and 5.0% $\pm$ 9.4% of the excluded-study set. Recall of included studies varied significantly by model and user role. ChatGPT achieved higher recall than Claude or Gemini (63.1% $\pm$ 29.5% vs. 37.0% $\pm$ 23.8% vs. 17.3% $\pm$ 13.1%; blocked permutation test, $p=2.0\times10^{-5}$), and the researcher role yielded higher recall than the clinician or patient roles (42.8% $\pm$ 30.8% vs. 38.6% $\pm$ 28.9% vs. 36.1% $\pm$ 29.3%; $p=2.0\times10^{-5}$). Controlling for publication year, citations per year, and open-access status, sample size was the only significant predictor of retrieval: each doubling of sample size was associated with 50% higher odds of retrieval (odds ratio 1.50, 95% CI 1.24-1.81). These findings show that LLM chatbots can retrieve studies identified by expert reviewers, but retrieval varies substantially across models and user roles and favors larger clinical trials.

0.34

SentryLine: Evidence-Grounded Question Answering over Evolving Documents in Oncology Care

cs.CL ·2026-09-08 ·Tampu Ravi Kumar, Gaurav Najpande, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Karan Kathuria +5 more
top venuebenchmark similarity 0.68
Abstract

Oncology care operates at constant pressure of absorbing rapidly evolving evidence base in biomedicine. The American Society of Clinical Oncology (ASCO) addresses this through living guidelines, but the format introduces a new burden: any recommendation can change at any point, across multiple versioned documents. We present SENTRYLINE, a living guideline-aware clinical question answering system. SENTRYLINE retrieves guideline passages through a vectorless hierarchical RAG pipeline and returns a role-specific answer with inline citations, factual and temporal verification reports, and drift detection notes that surface when a guideline has been updated. We construct ASCOBENCH, a benchmark of 405 three-turn conversations across four question categories with gold answers from expert annotators(clinicians), and use test set to evaluate SENTRYLINE against five baselines under an LLM-as-judge framework. Experiments across three generation backbones show consistent improvements over four retrieval baselines and ASCO's guideline assistant, with particularly strong gains on Reasoning and Role-Specific questions where multi-hop synthesis and register adaptation are required

0.69

An Agentic Generative Large Language Model for Treatment Planning of Colorectal Cancer

cs.CL ·2026-08-10 ·Mengxian Lyu, Cheng Peng, Tim Jang, Ang Li, Mengyuan Zhang +16 more
code/data similarity 0.66
Abstract

Treatment planning in precision oncology requires synthesizing heterogeneous patient information with rapidly evolving clinical guidelines to ensure guideline-concordant care. While large language models (LLMs) show promise in many diagnostic tasks, their adoption for high-stakes treatment planning is hindered by complex reasoning, adherence to timely clinical guidelines, and safety concerns. In this study, we present GatorOnco, an agentic LLM for colorectal cancer (CRC) treatment planning. GatorOnco is developed using a total of 282 billion tokens of biomedical text, including healthcare system-scale clinical text comprising 166 billion tokens from UF Health. We implemented a domain-adaptation method that integrates pre-training, model merging, a two-stage post-training approach, and agent-based reinforcement learning. An agentic retrieval-augmented generation (RAG) approach dynamically integrates time-sensitive clinical guidelines into the reasoning process. In a blind, randomized clinical evaluation conducted by five UF Health oncologists, GatorOnco significantly outperformed open-source LLMs (P < 0.01) and achieved expert-level performance comparable to UF Health oncologists. Compared with expert oncologists, GatorOnco received significantly higher ratings for readability (4.46 vs. 4.19, P < 0.01) and completeness (3.91 vs. 3.52, P < 0.01), while showing statistically comparable performance in correctness (4.09 vs. 4.11, P = 0.921), currency (4.04 vs. 3.98, P = 0.478), and safety (4.22 vs. 4.22, P = 0.999). These findings demonstrate that integrating agentic reasoning with large-scale domain adaptation can help bridge the gap for generative AI in high-stakes cancer treatment planning.

0.50

Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation

cs.AI cs.CL ·2026-08-31 ·Bahar İlgen, Yiannos Tolias, Denise Kühnert, Paraskevi Papadopoulou, Magnus Westerlund +3 more
similarity 0.66
Abstract · Review article

Artificial intelligence (AI) and natural language processing (NLP) are increasingly used to extract, integrate, and interpret biomedical knowledge relevant to cancer genomics, yet their translation into routine clinical oncology has been comparatively slow. The central challenge is not computational capability alone, but trustworthy integration into clinical workflows. This review examines how NLP and AI support the cancer genomics pipeline, from literature mining and automated variant interpretation to clinical trial matching, knowledge graph construction, and multimodal data integration. We identify four interrelated translational failure domains: evidence inconsistency, explainability and uncertainty, data governance and reproducibility, and interoperability. Rather than considering these challenges in isolation, we take a systems-level view, focusing on their interaction across the translational pathway. We propose a conceptual framework and roadmap for addressing these domains through rigorous validation, uncertainty-aware methods, interoperable infrastructures, regulatory alignment, and human oversight across the AI lifecycle. Progress toward routine clinical use will depend less on further improving model capability than on systematically addressing these interacting failure domains from development through deployment and post-deployment monitoring.

0.12

HerHealthGPT: An Evidence-Grounded Conversational AI System for Women's Reproductive Health

cs.CL ·2026-10-24 ·Hassan Saeed Hassan Albattra, Mazen Mohammed Bahgat, Rahatara Ferdousi, Hana Essam Sayed Ahmed Amrya, Mariam Mousa
similarity 0.66
Abstract

"Why is my period late?" Sometimes, the most useful response begins with another question. Yet conversational AI systems may respond to incomplete health queries without seeking essential context or grounding their guidance in verifiable evidence. This paper introduces HerHealthGPT, an evidence-grounded conversational AI system designed to address these challenges in women's reproductive health. HerHealthGPT integrates retrieval-augmented generation (RAG), context-aware clarification, and source validation within an interactive web interface. Rather than responding immediately to incomplete queries, the system maintains conversational context, asks targeted follow-up questions, checks for premature conclusions, and grounds its responses in retrieved evidence. We evaluate the AI components using 540 English messages derived from 90 reproductive-health cases and conduct a prototype questionnaire study with 30 adults. Evidence retrieval improves concern-category accuracy from 54.1% to 59.3% compared with fine-tuning alone. The clarification router achieves 85.6% recall and 86.2% specificity on constructed targets. In the user study, 83.3% of participants preferred the retrieval-enabled configuration, while 25 of 30 considered its follow-up questions relevant. These findings suggest that integrating evidence retrieval with interactive clarification offers a promising approach to more transparent, context-aware reproductive-health information systems, while further clinical validation remains necessary.

0.13

Development and Feasibility Evaluation of an Edge AI as Medical Device System for Breast Cancer Multidisciplinary Team Meetings

cs.AI cs.LG ·2026-08-22 ·Aarzoo Dhiman, Farzana Haque, Iqtedar Muazzam, Kartikae Grover, Lydia Brian Smith +1 more
benchmarkcode/data similarity 0.65
Abstract

Breast Cancer Multidisciplinary Team (MDT) meetings manage increasingly complex cases under considerable time pressure, and documentation requirements can reduce clinical efficiency and decision quality. Existing AI based MDT workflows rely on cloud-based processing, limiting their use because patient discussions contain identifiable information. We developed a fully on-device AI pipeline using open-source Automatic Speech Recognition (ASR) and Large Language Models (LLMs) that transcribes breast cancer MDT discussions, structures clinical information, and generates treatment recommendations using retrieval-augmented generation (RAG) grounded in National Institute for Health and Care Excellence (NICE) guidance. The pipeline runs on a single NVIDIA Jetson AGX Orin, ensuring that patient audio, transcripts, and outputs remain within institutional infrastructure. Evaluation included two recorded simulated MDT discussions, ten clinically validated synthetic discussions, and 1,270 acoustically augmented recordings. Optimisation of Whisper large-v3 reduced word error rate by 20.7% and 24.4% on the recorded discussions and achieved performance within 0.58% WER and 1.58% word information lost of a commercial clinical ASR benchmark on augmented audio. MedGemma-RAG identified 2.3 times more MDT-concordant interventions than a proprietary cloud comparator (p = 0.020), with no significant difference in overall accuracy. Stakeholders identified automated documentation, treatment recommendation support, and case triage as the most credible near-term applications while highlighting workflow integration, governance, and clinician trust as key implementation challenges. These findings demonstrate the feasibility of privacy-preserving, fully on-device AI for MDT documentation and guideline-informed decision support, providing a foundation for prospective clinical evaluation.

0.31